Life Sciences
Life Sciences
Common Pain Points
Reduced R&D Spending
Changing Politics, Expiring Programs and Limiting Qualifications
Collaboration
Costs are Rising and Availability is Shrinking
EBITDA / Rising Occupancy Costs
Inflection Point Reached in Supply & Demand of Industrial Space
Technology
Impacting Importing, Exporting and Logistics
Forecasting
How to plan for the next 3 – 5 years given the continued changing dynamics in the M&D space (specifically E-Commerce’s influence)